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Every time a cell divides, it must duplicate and segregate 
its chromosomes. Eukaryotic cells carry out these pro- 
cesses with remarkable order and fidelity. For example, 
in the yeast Saccharomyces cerevisiae, chromosome loss 
occurs at rates of only - 10 -5 per cell division. This preci- 
sion is achieved at four levels. First, chromosomes bear 
replication origins, centromeres, and telomeres, cis-acting 
structures essential for their stable maintenance. Second, 
there are many trans-acting factors, such as replication 
enzymes and spindle components, integral to the pro- 
cesses of replication and segregation. Third, there are cell 
cycle checkpoints, regulatory mechanisms that delay cell 
cycle progression when defects are detected in essential 
genetic structures, allowing repair prior to cell division. 
Finally, there are the repair activities themselves, activities 
that correct spontaneous or induced damage to the ge- 
nome. Although checkpoint and repair genes contribute 
to chromosome stability, genes whose sole function is to 
detect or repair DNA damage are not expected to be es- 
sential in the absence of DNA damage. Some genes act 
at multiple levels in ensuring genome integrity. For exam- 
ple, in Saccharomyces, DNA polymerase ~ serves not only 
as an essential replication enzyme but also as an S phase 
checkpoint gene and possibly as a DNA repair activity 
(Navas et al., 1995, and references therein). 
Ataxia telangiectasia (AT) is a human autosomal heredi- 
tary disease characterized by a wide spectrum of defects, 
including cerebellar degeneration, progressive mental re- 
tardation, uneven gait (ataxia), dilation of blood vessels 
(telangiectasia), immune deficiencies, premature aging, 
and an -100-fold increase in cancer susceptibility (re- 
viewed by Friedberg et al., 1995). Identification of the gene 
mutated in individuals suffering from AT revealed that 
most or all cases of this heterogeneous disease are 
caused by mutation of a single gene called ATM (Savitsky 
et al., 1995). Since some affected individuals carry ATM 
alleles that eliminate essentially the entire open reading 
frame (ORF), ATM is not an essential gene (Savitsky et 
al., 1995). Although the disease is recessive and relatively 
rare, heterozygotes, who make up - 1% of the population, 
also have an increased cancer risk. For example, it is esti- 
mated that heterozygosity at the ATM locus accounts for 
>/9% of breast cancers in the United States (Swift et al., 
1991; reviewed by Friedberg et al., 1995). Thus, under- 
standing the mechanism of action of ATM is of consider- 
able practical significance. 
At the cellular level, AT is characterized by chromosome 
abnormalities, including elevated numbers of spontane- 
ous and radiation-induced chromosome breaks and telo- 
mere-telomere fusions. Unlike normal cells, AT cells con- 
tinue to replicate their DNA in the presence of DNA 
damage, a hallmark of a defect in an S phase checkpoint. 
In addition, AT cells as well as individuals uffering from 
the disease are acutely sensitive to X-rays and X-ray mi- 
metic drugs. Heterozygotes display an intermediate radia- 
tion sensitivity. This phenotype is critical given that ATM 
heterozygotes have an increased risk of breast cancer, 
a risk that may be exacerbated by the very procedure, 
mammography, used to detect the disease. Taken to- 
gether, the cellular phenotypes associated with loss of 
ATM function suggest defects at any one or more of the 
levels required for maintaining genome integrity. 
Cloning and sequence analysis of an NH2-terminally 
truncated A TM cDNA revealed that it contains a large ORF 
(189 kDa) (Savitsky et al., 1995). The COOH-termina1400 
amino acids of its conceptual translation product have sim- 
ilarity to the catalytic domains of the - 100 kDa phospha- 
tidlyinositol 3-kinases (PI3Ks) from mammals (bovine 
p110, 24% identity) and Saccharomyces (Vps34, 21% 
identity) (Figure 1; reviewed by Kapeller and Cantley, 
1994). In addition to their lipid kinase activities, the mam- 
malian and Saccharomyces PI3Ks are also serine/threo- 
nine protein kinases (reviewed by Kapeller and Cantley, 
1994; Stack and Emr, 1994). Both the mammalian and 
the yeast proteins physically associate with a regulatory 
subunit that probably directs the PI3K to its targets or to 
its correct subcellular location (or both) (Kapeller and Cant- 
ley, 1994; Stack et al., 1995). The similarity to PI3Ks raises 
the interesting possibility that the ATM protein functions 
in signal transduction. 
ATM shows even more extensive similarity to several 
larger proteins in the database, all of which, like ATM, have 
motifs found in PI3Ks at their COOH-termini (Savitsky et 
al., 1995) (Figure 1). This family of ATM-related genes 
includes the Saccharomyces genes TOR1 and TOR2 as 
well as their mammalian homologs (FRAP and rRAFT), 
the Schizosaccharomyces pombe rad3 gene, and the Sac- 
charomyces ESR1/MEC1 gene (hereafter called MEC1). 
The yeast TOR proteins and their mammalian counter- 
parts appear to be required for the Gl-to-S transition 
(Brown et al., 1994; Sabatini et al., 1994, and references 
therein). For example, Saccharomyces cells that lack both 
Torlp and Tor2p arrest in G1 (Kunz et al., 1993). TOR2 
is required for an additional essential function in that cells 
lacking only Tor2p also die, but do so randomly with re- 
spect to the cell cycle (Helliwell et al., 1994). The S. pombe 
rad3 gene is a nonessential gene required for both the 
S-M and G2-M cell cycle checkpoints as well as directly 
for DNA repair (Jiminez et al., 1992; Seaton et al., 1992). 
Cells with mutations in rad3 are X-ray and ultraviolet (UV) 
sensitive, fail to arrest in G2 in response to DNA damage, 
and attempt mitosis even in the presence of a partially 
replicated genome. The MEC1 gene is an essential Sac- 
charomyces gene that, like the S. pombe rad3 gene, is 
required for both the S-M and G2-M checkpoints as well 
as for meiotic recombination (Weinert et al., 1994; Kato 
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Figure 1. Percent Identity and Similarity to 
ATM 
This figure is based on an analysis using Ge- 
netics Computer Group software carried out by 
J. Sekelsky from the Hawley laboratory. The 
figure presents the relatedness of predicted 
proteins encoded by genes containing PI3K 
motifs in their COOH-terminal regions. At the 
right the percent identity (I) and similarity (S) 
of both the kinase domains and the 1000 amino 
acids adjacent o the kinase domain relative to 
the human ATM gene are presented. For the 
kinase domain, A TM residues 1360-1708 (Sav- 
itsky et al., 1995) are compared. The adjacent 
region is the 1000 amino acids that precede 
the kinase domain. Individual proteins are de- 
scribed in the text. In brief, p110 is a bovine 
PI3K; Vps34 is a Saccharomyces PI3K; FRAP 
and rRAFT1 are, respectively, bovine and rat 
rapamycin-binding proteins; Torlp and Tor2p 
are Saccharomyces proteins; mei-41 is a Dro- 
sophila protein; Rad3 is an S. pembe protein; 
Meclp and Tellp are Saccharomyces pro- 
teins; and DNA-PI~s is a human protein. 
and Ogawa, 1994). As reported by Paulovich and Hartwell 
(1995 [this issue of Cell]), cells expressing a partial loss-of- 
function allele, mecl-1, like AT cells, fail to regulate DNA 
replication in the presence of DNA damage, suggesting 
that MEC1 is required for the S phase checkpoint as well. 
In this issue of Ceil, there are five papers that identify 
additional ATM-like genes, extend the phenotypes associ- 
ated with previously identified members of this group, or 
both (Hari et al., 1995; Greenwell et al., 1995; Morrow et 
al., 1995; Paulovich and Hartwell, 1995; Hartley et al., 
1995). Savitsky et al. (1995) noted an anonymous ORF, 
YBL088, identified through the Saccharomyces chromo- 
some II sequencing project (Feldmann et al., 1994) that 
could potentially encode a 322 kDa protein with the great- 
est similarity to ATM of the identified ATM-like genes (Fig- 
ure 1). This gene, called TEL1, was cloned independently 
by two groups (Greenwell et al., 1995; Morrow et al., 1995). 
Although TEL1 is predicted to encode a protein very similar 
to Meclp, the phenotypes of mutants in these genes are 
very different. Unlike MEC1 (but like ATM), TEL1 is not 
essential. In contrast with mecl-1 or AT cells, tellzl cells 
display no sensitivity to DNA-damaging agents and no ob- 
vious checkpoint defects (Morrow et al., 1995; Greenwell 
et al., 1995). The most marked defect associated with the 
absence of Tel lp is very short telomeres (Greenwell et 
al., 1995), an intriguing phenotype in light of the sugges- 
tions that AT cells have impaired telomere function (see 
above) and the demonstration that Saccharomyces telo- 
meres allow the G2-M checkpoint to distinguish intact 
from broken chromosomes (Sandell and Zakian, 1993). 
Although tellzl cells are not themselves sensitive to DNA- 
damaging agents, lack of Tell p in mecl-1 cells enhances 
their sensitivity to X-rays, UV, and hydroxyurea. Moreover, 
the double mutant, like AT cells, displays sensitivity to 
drugs that damage DNA such as bleomycin and streptoni- 
grin, to which neither mutant is sensitive (Morrow et al., 
1995). Finally, one or two extra copies of TEL1 can sup- 
press the lethality and radiation sensitivity of a truncation 
allele of MEC1 (Morrow et al., 1995). Thus, like the Sac- 
charomyces Torlp and Tor2p, Tel lp and Meclp have par- 
tially overlapping functions. Moreover, their phenotypes 
suggest that together they might carry out most or all of 
the functions of ATM in human cells. However, given that 
MEC1 is essential, Meclp must provide at least one activ- 
ity which in humans is supplied by a protein other than 
(or in addition to) ATM. 
Hari et al. (1995) report the cloning and sequencing of 
the Drosophila mei-41 gene and demonstrate that it, too, 
is an ATM-like gene (Figure 1). The authors point out that 
for mei-41 and other members of the A TM family, this simi- 
larity is not limited to the -300  amino acids at the COOH- 
terminus of the protein that contain the putative PI3K do- 
main but also includes an adjacent -1000 amino acids 
of lesser but significant similarity (Figure 1). mei-41 was 
identified by the reduced meiotic recombination associ- 
ated with its mutation (for earlier references on mei-41, 
see Hari et al., 1995). mei-41 cells are also highly sensitive 
to DNA-damaging agents, including X-rays, UV, methyl 
methanesulfonate, and hydroxyurea. Moreover, even in 
the absence of DNA damage, mei-41 cells have elevated 
numbers of broken chromosomes. Indeed, Hari et al. 
(1995) demonstrate that, in contrast with wild-type cells, 
mei-41 cells do not delay mitosis in response to X-irra- 
diation. Thus, cells lacking mei-41 have many of the phe- 
notypes of AT cells. 
The gene encoding the -460  kDa catalytic subunit of 
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the human DNA-dependent protein kinase (DNA-PKos), 
whose sequence is presented by Hartley et al. (1995), is 
also an ATM-like gene. Although DNA-PKos is less similar 
toATM than are several of the other members of this group 
(Hartley et al., 1995; Figure 1), it is the only ATM-like gene 
for which there is biochemical information on its mecha- 
nism of action (reviewed by Anderson, 1993). DNA-PK can 
be thought of as recognizing damaged DNA since it re- 
quires double-stranded breaks, nicks, or gaps for binding. 
The DNA-binding subunit of DNA-PK is Ku, a heterodimer 
of -70  and -80  kDa proteins, which binds directly to 
DNA and recruits the DNA-PKos protein to the complex. 
DNA-PK is a serine/threonine protein kinase that abso- 
lutely requires DNA for its activity. Rodent or human cells 
without DNA-PK activity, either because they lack Ku or 
DNA-PKos, are radiation sensitive, are repair deficient, and 
are unable to support V(D)J recombination (e.g., Rathmell 
and Chu, 1994; Taccioli et al., 1994; Finnie et al., 1995). 
Because DNA-PK~s, like other ATM-like genes, has motifs 
found in PI3Ks, Hartley et al. (1995) tested it directly for 
this activity. However, DNA-PK has no detectable lipid 
kinase activity, suggesting that it and, by extension, other 
ATM-like proteins are unlikely to function as PI3Ks. None- 
theless, DNA-PK provides an attractive paradigm for how 
ATM and related proteins might interact specifically with 
damaged DNA. 
Are any of these ATM-like genes true homologs ofA TM? 
The sequence comparisons from the Hawley and Jackson 
labs indicate that all of these proteins are more related to 
one another than they are to classical PI3Ks (Figure 1; 
Hari et al., 1995; Hartley et al., 1995). The gene in the 
ATM family most related to ATM is the Saccharomyces 
TEL1 gene, although the Drosophila mei-41 gene, the S. 
pombe rad3 gene, and the Saccharomyces MEC1 gene 
share not only a high level of sequence similarity but, as 
deduced from the phenotypes of mutants, many of the 
functions of ATM. However, all of the A TM-like genes differ 
considerably both from each other and from ATM in their 
NH2-terminal regions. Thus, true homologs of ATM may 
await discovery. 
Whether or not these ATM-like genes are ATM homo- 
logs, continued inquiry in genetically tractable model or- 
ganisms like yeast and Drosophila will surely provide valu- 
able insight into the functions of this family of proteins. It 
remains to be determined whether ATM-like proteins are 
PIs or protein kinases, whether they bind DNA, or whether 
they serve both roles. If they prove to be kinases or DNA- 
binding proteins, a combined genetic and biochemical 
strategy should establish whether these activities are es- 
sential for their function and should identify their in vivo 
substrates. Given the DNA-PK paradigm, a search for in- 
teracting proteins that might target ATM-like proteins to 
damaged DNA is clearly worthwhile. In this regard, it is 
of considerable interest hat Ku-related proteins have been 
identified in both Saccharomyces (Feldmann and Win- 
nacker, 1993) and Drosophila (Jacoby and Wensink, 
1994). Perhaps, the NH2-terminal regions of ATM-like pro- 
teins specify different protein-binding partners, thereby 
dictating the type of DNA damage recognized by the 
complex. 
References 
Anderson, C. W. (1993). Trends Biochem. Sci. 18, 433-437. 
Brown, E. J., Albers, M. W., Shin, T. B., Ichikawa, K., Keith, C. T., 
Lane, W. S., and Schreiber, S. L. (1994). Nature 369, 756-758. 
Feldmann, H., and Winnacker, E. L. (1993). J. Biol. Chem. 268, 12895- 
12900. 
Feldmann, H., Aigle, M., Aljinovic, G., Andre, B., Baclet, M. C., Barthe, 
C., Baur, A., Becam, A. M., Biteau, N., Boles, E., et al. (1994). EMBO 
J. 13, 5795-5809. 
Finnie, N. J., Gottlieb, T. M., Blunt, T., Jeggo, P. A., and Jackson, 
S. P. (1995). Proc. Natl. Acad. Sci. USA 92, 320-324. 
Friedberg, E. C., Walker, G. C., and Siede, W. (1995). DNA Repair and 
Mutagenesis (Washington, D. C.: American Society for Microbiology). 
Greenwell, P. W., Kronmal, S. L., Porter, S. E., Gassenhuber, J., Ober- 
maier, B., and Petes, T. D. (1995). Cell 82, this issue. 
Hari, K. L., Santerre, A., Sekelsky, J. J., McKim, K. S., Boyd, J. B., 
and Hawley, R. S. (1995). Cell 82, this issue. 
Hartley, K. O., Gell, D., Smith, G. C. M., Zhang, H., Divecha, N., Con- 
nelly, M. A., Admon, A., Lees-Miller, S. P., Anderson, C. W., and Jack- 
son, S. P. (1995). Cell 82, this issue. 
Helliwell, S. B., Wagner, P., Kunz, J., Deuter-Reinhard, M., Henriquez, 
R., and Hall, M. N. (1994). Mol. Cell. Biol. 5, 105-118. 
Jacoby, D. B., and Wensink, P. C. (1994). J. Biol. Chem. 269, 11484- 
11491. 
Jiminez, G., Yucel, J., Rowley, R., and Subramani, S. (1992). Proc. 
Natl. Acad. Sci. USA 89, 4952-4956. 
Kapeller, R., and Cantley, L. C. (1994). Bioessays 16, 565-576. 
Kato, R., and Ogawa, H. (1994). Nucl. Acids Res. 22, 3104-3112. 
Kunz, J., Henriquez, R., Schneider, U., Deuter-Reinhard, M., Movva, 
N. R., and Hall, M.N. (1993). Cell 73, 585-596. 
Morrow, D. M., Tagle, D. A., Shiloh, Y., Collins, F. S., and Hieter, P. 
(1995). Cell 82, this issue. 
Navas, T. A., Zhou, Z., and Elledge, S. J. (1995). Cell 80, 29-39. 
Paulovich, A. G., and Hartwell, L. H. (1995). Cell 82, this issue. 
Rathmell, W. K., and Chu, G. (1994). Proc. Natl. Acad. Sci. USA 91, 
7623-7627. 
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., and 
Snyder, S. H. (1994). Cell 78, 35-43. 
Sandell, L. L., and Zakian, V. A. (1993). Cell 75, 729-739. 
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, 
L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, 
I., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., 
Sanal, O., Lavin, M. F., Jaspers, N. G. J., Taylor, A. M. R., Arlett, 
C. F., Miki, T., Weissman, S. M, Lovett, M., Collins, F. S., and Shiloh, 
Y. (1995). Science 268, 1749-1753. 
Seaton, B. L., Yucel, J., Sunnerhagen, P., and Subramani, S. (1992). 
Gene 119, 83-89. 
Stack, J. H., and Emr, S. D. (1994). J. Biol. Chem. 269, 31552-31562. 
Stack, J. H., DeWald, D. B., Takegawa, K., and Emr, S. D. (1995). J. 
Cell. Biol. 129, 321-334. 
Swift, M., Morrell, D., Massey, R. B., and Chase, C. L. ,{1991). N, Engl. 
J. Med. 325, 1831-1836. 
Taccioli, G. E., Gottlieb, T. M., Blunt, T., Priestley, A., Demengeot, 
J., Mizuta, R., Lehrnann, A. FI., AIt, F. W., Jackson, S. P., and Jeggo, 
P. A. (1994). Science 265, 1442-1445. 
Weinert, T. A., Kiser, G. L., and Hartwell, L. H. (1994). Genes Dev. 
8, 652-665. 
